Latest News and Press Releases
Want to stay updated on the latest news?
-
WALTHAM, Mass., Oct. 11, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company dedicated to providing the most accurate and actionable information possible across multiple cancers to enhance drug...
-
WALTHAM, Mass., April 2, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company dedicated to providing the most accurate and actionable information possible across multiple cancers to enhance drug...
-
WALTHAM, Mass., March 27, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company dedicated to providing the most accurate and actionable information possible across multiple cancers to enhance...
-
WALTHAM, Mass., Feb. 17, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company focused on novel circulating tumor cell (CTC) capture and characterization for clinical researchers and physicians...
-
WALTHAM, Mass., Feb. 15, 2012 (GLOBE NEWSWIRE) -- On-Q-ity, a life sciences company focused on novel circulating tumor cell (CTC) capture and characterization for clinical researchers and physicians...
-
WALTHAM, Mass., July 21, 2011 (GLOBE NEWSWIRE) -- On-Q-ity, a company developing next-generation CTC technology to improve the effectiveness of cancer therapies, today announced that using their...
-
WALTHAM, Mass., April 6, 2011 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation personalized diagnostics company dedicated to improving cancer therapy effectiveness, today announced that its novel,...
-
WALTHAM, Mass., Jan. 10, 2011 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today...
-
WALTHAM, Mass., Nov. 16, 2010 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today...
-
WALTHAM, Mass., Oct. 18, 2010 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing personalized tests to improve cancer therapy effectiveness, today announced it...